These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 12219268)
1. [Oral antibiotics with antiinflammatory/ immunomodulatory effects in the treatment of various dermatoses]. Brinkmeier T; Frosch PJ Hautarzt; 2002 Jul; 53(7):456-65. PubMed ID: 12219268 [TBL] [Abstract][Full Text] [Related]
2. Immunomodulation in autoimmune diseases. Gergely P; Láng I; Gonzalez-Cabello R; Fehér J Tokai J Exp Clin Med; 1986; 11 Suppl():207-13. PubMed ID: 3452243 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activity of tetracyclines. Webster G; Del Rosso JQ Dermatol Clin; 2007 Apr; 25(2):133-5, v. PubMed ID: 17430750 [TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease. Magro CM; Dyrsen ME J Am Acad Dermatol; 2008 Nov; 59(5):822-33. PubMed ID: 19119098 [TBL] [Abstract][Full Text] [Related]
7. [Role of corticoid-antibiotic combinations in local treatments. Critical study]. Revuz J; Duterque M; Escande JP Ann Dermatol Venereol; 1983; 110(12):1007-10. PubMed ID: 6364924 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of aging skin: cutaneous disorders in the elderly. Farage MA; Miller KW; Berardesca E; Maibach HI Am J Clin Dermatol; 2009; 10(2):73-86. PubMed ID: 19222248 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune bullous dermatoses: a review. Patrício P; Ferreira C; Gomes MM; Filipe P Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152 [TBL] [Abstract][Full Text] [Related]
11. Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors. Tan EH; Chan A Ann Pharmacother; 2009 Oct; 43(10):1658-66. PubMed ID: 19755624 [TBL] [Abstract][Full Text] [Related]
12. Combined activation of innate and T cell immunity for recognizing immunomodulatory properties of therapeutic agents. Rose B; Herder C; Löffler H; Kolb H; Martin S J Leukoc Biol; 2004 Apr; 75(4):624-30. PubMed ID: 14704370 [TBL] [Abstract][Full Text] [Related]
13. Common and alternate oral antibiotic therapies for acne vulgaris: a review. Amin K; Riddle CC; Aires DJ; Schweiger ES J Drugs Dermatol; 2007 Sep; 6(9):873-80. PubMed ID: 17941358 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data. Gürcan HM; Ahmed AR Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739 [TBL] [Abstract][Full Text] [Related]
17. Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. Orfanos CE; Bauer R Br J Dermatol; 1983 Jul; 109 Suppl 25():55-60. PubMed ID: 6222758 [TBL] [Abstract][Full Text] [Related]
18. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus. Toubi E; Kessel A; Shoenfeld Y Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703 [TBL] [Abstract][Full Text] [Related]
19. [Practical management of the most common autoimmune bullous diseases]. Suárez-Fernández R; España-Alonso A; Herrero-González JE; Mascaró-Galy JM Actas Dermosifiliogr; 2008; 99(6):441-55. PubMed ID: 18558052 [TBL] [Abstract][Full Text] [Related]
20. Systemic vasculitis: still a challenging disease. Buhaescu I; Covic A; Levy J Am J Kidney Dis; 2005 Aug; 46(2):173-85. PubMed ID: 16112036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]